AzTrials
AzTrials

Multiple Sclerosis, Relapsing-RemittingBIPAMS-SDNCT04768777

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

A study testing Behavioural intervention for physical activity for multiple sclerosis (BIPAMS) in people with Multiple Sclerosis, Relapsing-Remitting and Sexual Dysfunction, run by University of Alabama at Birmingham at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The prevalence of sexual dysfunction is higher among women with multiple sclerosis (MS) than women in the general population. The presence of sexual dysfunction is associated with decreased well-being and quality of life. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
What is being tested?
Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
1 Dec 2026to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female
  • Diagnosed of relapsing remmiting multiple sclerosis
  • Relapse free in the past 30 days
  • Initial confirmation of sexual dysfunction (based on a semi-structured interview on sexual dysfunction diagnostic criteria in DSM-5)
  • Currently in a committed relationship with a partner who does not have a sexual disorder or sexual dysfunction
  • Internet and email access
Show all 12Show fewer
  • Willingness to complete the questionnaires, wear the pedometer, and undergo randomization
  • Insufficient physical activity [not meeting current physical activity guidelines based on a health contribution score of less than 14 units from the Godin Leisure-Time Exercise Questionnaire (GLTEQ)]
  • Ability to ambulate without assistance [self-report and Patient-Determined Disease Steps (PDDS) score between 0 and 2 (mild ambulatory disability)]
  • Age between 18 and 45 years
  • English as primary language
  • -

Who cannot join

  • 1. Moderate or high risk for contraindications of possible injury or death when undertaking strenous or maximal exercise
  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Donald Lein, PhD contact

2059340241

dlein@uab.edu

Ashlie Ithurburn contact

2059751306

akji@uab.edu

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35243

Other trials in United States

About this study

The prevalence of sexual dysfunction is higher among women with multiple sclerosis (MS) than women in the general population. The presence of sexual dysfunction is associated with decreased well-being and quality of life. There is limited research supporting pharmacological and other therapeutic approaches for managing sexual dysfunction in MS. Physical activity has beneficial effects on many of the consequences of MS, and physical activity represents a promising non-pharmacological approach for managing symptoms of sexual dysfunction in MS. The proposed research examines the effect of an Internet-delivered lifestyle physical activity intervention for improving sexual dysfunction in women with MS. The research proposed, if successful, will provide evidence for the efficacy of physical activity as a translatable approach for managing sexual dysfunction among women with MS.

Being tested
Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
Keywords
physical activity, sexual behaviour
Medical subject headings
Multiple Sclerosis, Relapsing-Remitting, Sexual Dysfunction, Physiological, Motor Activity, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)Behavioural

    The current behavioral intervention consists of two primary components; an internet website and one-on-one video chats with a behavioral coach. The internet website involves content delivered through interactive video courses.The interactive video courses are based on elements of social cognitive theory. Each course consists of an introduction, the primary content, and a take home message.The interactive courses include embedded, supplementary options such as videos on content and worksheets related to the topic.A pedometer is provided for tracking steps, and these steps will be entered into the website so progress can be monitored. The chats support adherence to the intervention,discussion of website material,supportive accountability,and reporting of adverse events/injuries. The chats are conducted face-to-face through an online videoconferencing platform. There are a total of 12 chats over 16 weeks. Chats occur on weeks 1-8, 10-11, 13 and16.

Study groups in NCT04768777
Study groupRoleWhat they receive
Behavioral Intervention for Physical Activity in MS (BIPAMS)ExperimentalA behavioral intervention that involves an internet website and one-on-one video coaching calls for increasing physical activity in people with MS.
Receives: Behavioral: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
waitlist control conditionNo interventionParticipants will have 16-weeks of no intervention or interaction.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline Sexual Dysfunction at 16 weeks

    The Female Sexual Function Index (FSFI): is a common generic measure of sexual dysfunction for women. The questionnaire consists of 19 questions that cover six subscales/domains of sexual function: sexual desire, sexual arousal, lubrication, orgasm, sexual satisfaction, and pain. The items further yield an overall score. Lower sum scores reflect more pronounced sexual dysfunction.

    Measured: Baseline, week 16

Secondary outcomes (3)
  1. Change from baseline Sexual Dysfunction in MS at 16 weeks

    The Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-19) is the most widely used self-rating tool for sexual functions in MS (Sanders et al., 2000). The MSISQ-19 consists of 19 items focusing on the perceived influence of MS symptoms on sexual activity and satisfaction and the perceived influence of MS symptoms on the overall quality of intimate relationships. The scores classifies the type of sexual dysfunction in to primary, secondary, or tertiary sexual dysfunction.

    Measured: Baseline, week 16

  2. Change from baseline Physical activity at 16 weeks

    GLTEQ: Physical Activity Levels as measured by the Godin Leisure-Time Exercise Questionnaire. Participants will complete the Godin Leisure-Time Exercise Questionnaire (GLTEQ) as a measure of the frequency of strenuous, moderate, and mild leisure-time physical activity performed for periods of 15 minutes or more over a typical week. Summary scores are calculated by multiplying the number of strenuous, moderate, and mild bouts by 9, 5, and 3, respectively, and summing those values into an overall score that ranges from 0 to 119; higher scores are represent a greater volume of physical activity. This will be completed at baseline testing.

    Measured: Baseline, week 16

  3. Change from baseline physical activity duration at 16 weeks

    International Physical Activity Questionnaire (IPAQ). The IPAQ was developed by a working group initiated by the World Health Organization and the Centers for Disease Control and Prevention. The IPAQ asks participants about time spent in physical activity over the last seven days. Minutes of walking, sedentary-, moderate- and vigorous-intensity activities were calculated for the past week.

    Measured: Baseline, week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2021
  2. Study start1 Dec 2026 (estimated)
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04768777
Sponsor's protocol ID
IRB-300006813
Acronym
BIPAMS-SD
Status last verified
Dec 2025
First submitted
10 Feb 2021
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioural intervention for physical activity for multiple sclerosis (BIPAMS) in people with Multiple Sclerosis, Relapsing-Remitting and Sexual Dysfunction, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Donald Lein, PhD (2059340241, dlein@uab.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline Sexual Dysfunction at 16 weeks (time frame: Baseline, week 16). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in